![]() |
||||
|
|
||||
|
|
||||
|
Re: Pregnancy and Indocin (Indomethacin).From: R. Daniel Braun, MD (anonymous@obgyn.net)Fri, 22 Dec 2000 09:08:59 -0600 (CST)
At Fri, 22 Dec 2000, Shah wrote: > >I am 14wk3dy pregnant with twins and had a cervical cerclage placed >yesterday. My OB has me on the anti-inflammatory, Indocin 25mg, 10 >capsules to be taken over 3 days (I'm actually taking the generic, >Indomethacin). I noticed the pharmacist "cautions" included that this >medication is harmful to fetus. I called my pharmacist who said studies >were inconclusive then called my OB who said harm to fetus w/Indocin is >only if taken in high doses. Can you help clear this up for me? I am >fearful of taking my next dose today with this kind of warning. Should >I push for another anti-inflammatory or is this dosage safe? > >Thank you. > >-- >Shah > Here is the abstract of a review article on the use of Indomethacin. The reference is also available so that you can obtain a copy if you wish. Most libriaries should hav ethis service available. Before you read it, let me say that I believe that a short course 3-4 days at this stage(14 weeks) in pregnancy is probably safe. RDB Prostaglandin synthetase inhibitors in pregnancy. Obstet Gynecol Surv 1993 Jul;48(7):493-502 (ISSN: 0029-7828) Van den Veyver IB; Moise KJ Jr Department of Obstetrics and Gynecology, Baylor College of Medicine, Houston, Texas 77030. The use of indomethacin as a tocolytic agent in patients with premature labor was first reported by Zuckerman in 1974. Since then, prostaglandin synthetase inhibitors (PSI) have been used in pregnancy for a variety of indications. However, serious fetal side effects of this category of drugs continue to be reported. We present a review of the literature and the experience at our institution on the use of indomethacin, the most commonly prescribed antiprostaglandin in pregnancy. Therapeutic guidelines and surveillance recommendations for the use of PSI in pregnancy are proposed. The role of newer PSI in pregnancy and their side effect profile are also presented. Major Subject Heading(s) Minor Subject Heading(s) CAS Registry / EC Numbers Cyclooxygenase Inhibitors [therapeutic use] Pregnancy Complications [prevention & control] Cyclooxygenase Inhibitors [adverse effects] [contraindications] Fetal Diseases [chemically induced] [prevention & control] Forecasting Indomethacin [therapeutic use] Labor, Premature [prevention & control] Pregnancy Complications [chemically induced] Pregnancy 0 (Cyclooxygenase Inhibitors) 53-86-1 (Indomethacin) Indexing Check Tags: Animal; Female; Human Language: English MEDLINE Indexing Date: 199311 Publication Type: JOURNAL ARTICLE; REVIEW (129 references); REVIEW, TUTORIAL Unique NLM Identifier: 93361296 Journal Code: M
-- R.Daniel Braun, MD FACOG FOG
|
| |
Women's Insurance Checklist from Auto Insurance Quote home | medical professionals | women | industry | forums | internationale-mail | about us | advertising | our sponsors | contact us | disclaimer | This information is provided for educational purposes only. Please read the disclaimer. ©1996-2008, all rights reserved. Do not reproduce without permission of MediSpecialty.com |